Media coverage about Sabra Healthcare REIT (NASDAQ:SBRA) has been trending somewhat positive recently, Accern Sentiment reports. The research firm rates the sentiment of media coverage by reviewing more than 20 million blog and news sources. Accern ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. Sabra Healthcare REIT earned a media sentiment score of 0.18 on Accern’s scale. Accern also gave news coverage about the real estate investment trust an impact score of 47.2330359971495 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the near future.

Here are some of the media stories that may have impacted Accern’s rankings:

Shares of Sabra Healthcare REIT (NASDAQ:SBRA) opened at $19.05 on Friday. The company has a market cap of $3,386.41, a P/E ratio of 8.33, a PEG ratio of 2.47 and a beta of 0.92. Sabra Healthcare REIT has a 1 year low of $18.48 and a 1 year high of $29.10. The company has a debt-to-equity ratio of 0.89, a current ratio of 1.66 and a quick ratio of 1.66.

The firm also recently declared a quarterly dividend, which was paid on Thursday, November 30th. Stockholders of record on Wednesday, November 15th were given a $0.07 dividend. The ex-dividend date of this dividend was Tuesday, November 14th. This represents a $0.28 annualized dividend and a dividend yield of 1.47%. Sabra Healthcare REIT’s dividend payout ratio is presently 221.28%.

Several brokerages have weighed in on SBRA. Zacks Investment Research lowered shares of Sabra Healthcare REIT from a “buy” rating to a “hold” rating in a research report on Wednesday, August 30th. Mizuho upgraded shares of Sabra Healthcare REIT from an “underperform” rating to a “neutral” rating and upped their target price for the stock from $23.00 to $24.00 in a research report on Monday, September 11th. Jefferies Group upgraded shares of Sabra Healthcare REIT from a “hold” rating to a “buy” rating and set a $25.00 target price on the stock in a research report on Tuesday, August 15th. ValuEngine lowered shares of Sabra Healthcare REIT from a “buy” rating to a “hold” rating in a research report on Friday, September 1st. Finally, Bank of America upped their target price on shares of Sabra Healthcare REIT from $21.00 to $22.00 and gave the stock an “underperform” rating in a research report on Friday, September 8th. Two research analysts have rated the stock with a sell rating, five have given a hold rating and five have assigned a buy rating to the company. The stock has an average rating of “Hold” and a consensus target price of $24.40.

In other news, Director Milton J. Walters sold 4,615 shares of the stock in a transaction that occurred on Thursday, November 30th. The shares were sold at an average price of $19.18, for a total value of $88,515.70. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. 2.60% of the stock is owned by corporate insiders.

WARNING: “Sabra Healthcare REIT (SBRA) Receives Media Impact Rating of 0.18” was first posted by TheOlympiaReport and is owned by of TheOlympiaReport. If you are viewing this article on another publication, it was illegally stolen and republished in violation of US and international copyright and trademark laws. The original version of this article can be viewed at

About Sabra Healthcare REIT

Sabra Health Care REIT, Inc is a real estate investment trust. The Company, through its subsidiaries, owns and invests in real estate serving the healthcare industry. The Company’s segment includes investments in healthcare-related real estate properties. The Company’s primary business consists of acquiring, financing and owning real estate property to be leased to third-party tenants in the healthcare sector.

Insider Buying and Selling by Quarter for Sabra Healthcare REIT (NASDAQ:SBRA)

Receive News & Ratings for Sabra Healthcare REIT Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Healthcare REIT Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.